REVIEW PAPER
The role of nutrition and dietary supplements in the management of diarrhoea in HIV patients: a review of the literature
1
Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
2
Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico
3
Department of Nutrition and Dietetic, Centro Médico Militar, Guatemala City, Guatemala
4
Nutrition Division, Hospital 20 de Noviembre, ISSSTE, Mexico City, Mexico
Submission date: 2019-02-28
Final revision date: 2019-06-03
Acceptance date: 2019-06-07
Publication date: 2019-09-09
HIV & AIDS Review 2019;18(3):158-164
KEYWORDS
TOPICS
ABSTRACT
Diarrhoea is present in 28-60% of people living with human immunodeficiency virus (HIV). This condition is associated with malabsorption, nutritional risk, and higher incidence of infections and is one of the main causes of morbidity and mortality. Diarrhoea may be classified by duration and aetiology. Acute and chronic diarrhoea causes a reduction in dietary intake and also reduces the ability to absorb nutrients, leading to patient malnutrition and impacting their quality of life. The medical treatment for infectious diarrhoea is the eradication of pathogens; however, there is no specific treatment for non-infectious diarrhoea, which suggests the use of antisecretory medications, antimotility, and adsorbent agents. The use of non-pharmacological strategies such as the dietary modifications and nutrition supplements, specifically zinc, elemental diets, glutamine, fibre, and probiotics may decrease the duration of diarrhoea and may ameliorate the frequency and consistency of stool depositions. The goal of nutritional intervention is to promote the intake of energy and protein amounts needed to maintain or improve the nutritional status and quality of life. Despite promising data in individual strategies, further studies are needed to evaluate the multiple approaches in clinical practice. In this review, we aim to summarise the nutritional management and supplementation strategies for diarrhoea in HIV patients.
REFERENCES (64)
1.
Logan C, Beadsworth MBJ, Beeching NJ. HIV and diarrhoea: what is new? Curr Opin Infect Dis 2016; 29: 486-494.
2.
Hall VP. Common gastrointestinal complications associated with human immunodeficiency virus/AIDS: an overview. Crit Care Nurs Clin North Am 2018; 30: 101-107.
3.
Assimakopoulos SF, Dimitropoulou D, Marangos M, Gogos CA. Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies. Infection 2014; 42: 951-959.
4.
World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers. World Health Orga-nization, Geneva 2005.
5.
Reintam Blaser A, Deane AM, Fruhwald S. Diarrhoea in the critically ill. Curr Opin Crit Care 2015; 21: 142-153.
6.
Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol 2016; 111: 602-622.
7.
Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis 2017; 65: 1963-1973.
8.
Zevin AS, McKinnon L, Burgener A, Klatt NR. Microbial translocation and microbiome dsybiosis in HIV-associated immune activation. Curr Opin HIV AIDS 2016; 11: 182-190.
9.
Dikman AE, Schonfeld E, Srisarajivakul NC, Poles MA. Human immunodeficiency virus-associated diarrhea: still an issue in the era of antiretroviral therapy. Dig Dis Sci 2015; 60: 2236-2245.
10.
Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 2009; 136: 1952-1965.
11.
Clay PG, Crutchley RD. Noninfectious diarrhea in HIV seropositive individuals: a review of prevalence rates, etiology, and management in the era of combination antiretroviral therapy. Infect Dis Ther 2014; 3: 103-122.
12.
Wierdsma NJ, Peters JHC, Weijs PJM, et al. Malabsorption and nutritional balance in the ICU: fecal weight as a biomarker: a prospective observational pilot study. Crit Care 2011; 15: R264.
13.
Gorospe EC, Oxentenko AS. Nutritional consequences of chronic diarrhoea. Best Pract Res Clin Gastroenterol 2012; 26: 663-675.
14.
Siddiqui U, Bini EJ, Chandarana K, et al. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. J Clin Gastroenterol 2007; 41: 484-490.
15.
Mata L. Diarrheal disease as a cause of malnutrition. Am J Trop Med Hyg 1992; 47: 16-27.
16.
MacArthur RD, DuPont HL. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis Off Publ Infect Dis Soc Am 2012; 55: 860-867.
17.
Li Z, Vaziri H. Treatment of chronic diarrhoea. Best Pract Res Clin Gastroenterol 2012; 26: 677-687.
18.
Schiller LR. Nutrition management of chronic diarrhea and malabsorption. Nutr Clin Pract 2006; 21: 34-39.
19.
Capili B, Anastasi JK. Body mass index and nutritional intake in patients with HIV and chronic diarrhea: a secondary analysis. J Am Acad Nurse Pract 2008; 20: 463-470.
20.
Osuna-Padilla IA, Aguilar-Vargas A, Villazón-De la Rosa A, et al. Accuracy of predictive equations for energy expenditure in Mexicans living with HIV/AIDS with and without antiretroviral therapy. JPEN J Parenter Enteral Nutr 2018; 42: 380-386.
21.
Willig A, Wright L, Galvin TA. Practice paper of the Academy of Nutrition and Dietetics: nutrition intervention and human immunodeficiency virus infection. J Acad Nutr Diet 2018; 118: 486-498.
22.
Polo R, Gómez-Candela C, Miralles C, et al. Recomendaciones de SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA sobre nutrición en el paciente con infección por VIH. Nutr Hosp 2007; 22: 229-243.
23.
Anastasi JK, Capili B, Kim AG, McMahon D, Heitkemper MM. Symptom management of HIV-related diarrhea by using normal foods: a randomized controlled clinical trial. J Assoc Nurses AIDS Care JANAC 2006; 17: 47-57.
24.
Zahedi MJ, Behrouz V, Azimi M. Low fermentable oligo-di-monosaccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial. J Gastroenterol Hepatol 2018; 33: 1192-1199.
25.
Gecse K, Róka R, Séra T, et al. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion 2012; 85: 40-46.
26.
Herzog K, Williams R, Cho I, Tenner C, Poles M. Irritable bowel syndrome and HIV: a cross sectional study of the severity of gastrointestinal symptoms and HIV-infected subjects: 1302. Am J Gastroenterol 2010; 105: S479.
27.
Shariati A, Fallah F, Pormohammad A, et al. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. J Cell Physiol 2019; 234: 8550-8569.
28.
Pedersen N, Ankersen DV, Felding M, et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23: 3356-3366.
29.
Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A Controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013; 144: 903-911.e3.
30.
Alexander DD, Bylsma LC, Elkayam L, Nguyen DL. Nutritional and health benefits of semi-elemental diets: a comprehensive summary of the literature. World J Gastrointest Pharmacol Ther 2016; 7: 306-319.
31.
Salomon SB, Jung J, Voss T, Suguitan A, Rowe WB, Madsen DC. An elemental diet containing medium-chain triglycerides and enzymatically hydrolyzed protein can improve gastrointestinal tolerance in people infected with HIV. J Am Diet Assoc 1998; 98: 460-462.
32.
Craig GB, Darnell BE, Weinsier RL, et al. Decreased fat and nitro¬gen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc 1997; 97: 605-611.
33.
Ockenga J, Grimble R, Jonkers-Schuitema C, et al. ESPEN Guidelines on enteral nutrition: wasting in HIV and other chronic infectious diseases. Clin Nutr 2006; 25: 319-329.
34.
Edwards WM, Drexler AM, Aboulafia DM, McCormick WC. Efficacy of total parenteral nutrition in a series of end-stage AIDS patients: a case-control study. AIDS Patient Care STDs 1997; 11: 323-329.
35.
Worthington P, Balint J, Bechtold M, et al. When is parenteral nutrition appropriate? JPEN J Parenter Enteral Nutr 2017; 41: 324-377.
36.
WHO. Nutritional care and support for people living with HIV/AIDS. WHO n.d. Available at: http://www.who.int/nutrition/p... (Accessed: 3.06.2019).
37.
Scrimgeour AG, Lukaski HC. Zinc and diarrheal disease: current status and future perspectives. Curr Opin Clin Nutr Metab Care 2008; 11: 711-717.
38.
WHO. Zinc supplementation in the management of diarrhoea. WHO n.d. Available at: http://www.who.int/elena/title... (Accessed: 30.10.2018).
39.
Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2016; 12: CD005436.
40.
Cárcamo C, Hooton T, Weiss NS, et al. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J Acquir Immune Defic Syndr 2006; 43: 197-201.
41.
Baum MK, Lai S, Sales S, Page JB, Campa A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis 2010; 50: 1653-1660.
42.
Zeng L, Zhang L. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systema-tic review. Trop Med Int Health 2011; 16: 1474-1482.
43.
Achamrah N, Déchelotte P, Coëffier M. Glutamine and the regulation of intestinal permeability: from bench to bedside. Curr Opin Clin Nutr Metab Care 2017; 20: 86-91.
44.
Noyer CM, Simon D, Borczuk A, Brandt LJ, Lee MJ, Nehra V. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am J Gastroenterol 1998; 93: 972-975.
45.
Bushen OY, Davenport JA, Lima AB, et al. Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl- glutamine in a randomized controlled trial in Northeast Brazil. Clin Infect Dis 2004; 38: 1764-1770.
46.
Huffman FG, Walgren ME. L-glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials 2003; 4: 324-329.
47.
Leite RD, Lima NL, Leite CAC, Farhat CK, Guerrant RL, Lima AAM. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial. Arq Gastroenterol 2013; 50: 56-63.
48.
Bertrand J, Ghouzali I, Guérin C, et al. Glutamine restores tight junction protein claudin-1 expression in colonic mucosa of patients with diarrhea-predominant irritable bowel syndrome. JPEN J Parenter Enteral Nutr 2016; 40: 1170-1176.
49.
Vanek VW, Matarese LE, Robinson M, et al. A.S.P.E.N. position paper: parenteral nutrition glutamine supplementation. Nutr Clin Pract 2011; 26: 479-494.
50.
Generoso S de V, Lages PC, Correia MITD. Fiber, prebiotics, and diarrhea: what, why, when and how. Curr Opin Clin Nutr Metab Care 2016; 19: 388-393.
51.
. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016; 40: 159-211.
52.
McFarland LV, Goh S. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: a systematic review and meta-analysis. Travel Med Infect Dis 2019; 27: 11-19.
53.
Sherman DS, Fish DN. Management of protease inhibitor-associated diarrhea. Clin Infect Dis 2000; 30: 908-914.
54.
McRorie JW, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet 2017; 117: 251-264.
56.
Lertpipopmetha K, Kongkamol C, Sripongpun P. Effect of psyllium fiber supplementation on diarrhea incidence in enteral tube-fed patients: a prospective, randomized, and controlled trial. JPEN J Parenter Enteral Nutr 2019; 43: 759-767.
57.
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-514.
58.
Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; 11: CD003048.
59.
Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 2010; 11: CD007401.
60.
D’Angelo C, Reale M, Costantini E, D’Angelo C, Reale M, Costantini E. Microbiota and probiotics in health and HIV Infection. Nutrients 2017; 9: 615.
61.
Carter GM, Esmaeili A, Shah H, et al. Probiotics in human immunodeficiency virus infection: a systematic review and evidence synthesis of benefits and risks. Open Forum Infect Dis 2016; 3: ofw164.
62.
Santos ASEA de C, Silveira EA da, Falco MO, Nery MW, Turchi MD. Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: Randomized clinical trial. Clin Nutr 2017; 36: 680-685.
63.
Wilson NL, Moneyham LD, Alexandrov AW. A systematic review of probiotics as a potential intervention to restore gut health in HIV infection. J Assoc Nurses AIDS Care 2013; 24: 98-111.
64.
Stadlbauer V. Immunosuppression and probiotics: are they effective and safe? Benef Microbes 2015; 6: 823-828.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
